SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+19.44%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.38B
AUM Growth
+$2.38B
(+0.26%)
Cap. Flow
-$155M
Cap. Flow
% of AUM
-6.52%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
113
New
41
Increased
19
Reduced
15
Closed
24
Top Buys
| 1 |
Nike
NKE
|
$58.3M |
| 2 |
Wynn Resorts
WYNN
|
$56.5M |
| 3 |
AT&T
T
|
$54.3M |
| 4 |
Biohaven
BHVN
|
$52.6M |
| 5 |
Colgate-Palmolive
CL
|
$50.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$89.1M |
| 2 |
Walt Disney
DIS
|
$87.4M |
| 3 |
Amazon
AMZN
|
$82.9M |
| 4 |
IQVIA
IQV
|
$72.7M |
| 5 |
Global Payments
GPN
|
$71.2M |
Sector Composition
| 1 | Healthcare | 46.26% |
| 2 | Consumer Discretionary | 16.29% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Staples | 8.08% |
| 5 | Technology | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $136M | 5.72% | 256,714 +15,717 | +7% | +$8.33M |
|
2
Union Pacific
UNP
$133B
| $108M | 4.53% | 521,173 -11,932 | -2% | -$2.47M |
|
3
Otis Worldwide
OTIS
$33.9B
| $102M | 4.27% | 1,297,480 | – | – |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $99.5M | 4.18% | 874,291 +161,730 | +23% | +$18.4M |
|
5
Estee Lauder
EL
$33B
| $98.9M | 4.15% | 398,506 +28,923 | +8% | +$7.18M |
|
6
Tapestry
TPR
$21.2B
| $83M | 3.49% | 2,180,922 | – | – |
|
7
Kura Oncology
KURA
$686M
| $79.1M | 3.32% | 6,376,815 +2,313,687 | +57% | +$28.7M |
|
8
Las Vegas Sands
LVS
$39.6B
| $78.1M | 3.28% | 1,625,685 -768,266 | -32% | -$36.9M |
|
9
Royalty Pharma
RPRX
$15.6B
| $78M | 3.28% | 1,974,625 +131,907 | +7% | +$5.21M |
|
10
Arcellx
ACLX
$3.85B
| $72.8M | 3.06% | 2,350,333 +100,800 | +4% | +$3.12M |
|
|
11
Nike
NKE
$114B
| $58.3M | 2.45% | +497,937 | New | +$58.3M |
|
12
Canadian Pacific Kansas City
CP
$69.9B
| $57.1M | 2.4% | 765,840 -10,436 | -1% | -$778K |
|
|
13
Wynn Resorts
WYNN
$13.2B
| $56.5M | 2.37% | +685,001 | New | +$56.5M |
|
14
Hilton Worldwide
HLT
$64.9B
| $55.2M | 2.32% | 436,756 -108,415 | -20% | -$13.7M |
|
|
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $54.9M | 2.3% | 1,036,948 +184,990 | +22% | +$9.79M |
|
|
16
AT&T
T
$209B
| $54.3M | 2.28% | +2,951,900 | New | +$54.3M |
|
|
17
Biohaven
BHVN
$1.63B
| $53.4M | 2.24% | 3,848,938 +3,787,307 | +6,145% | +$52.6M |
|
|
XYZ
18
Block, Inc.
XYZ
$48.5B
| $53.1M | 2.23% | 844,303 +182,763 | +28% | +$11.5M |
|
|
19
Colgate-Palmolive
CL
$67.9B
| $50.8M | 2.13% | +644,580 | New | +$50.8M |
|
20
Insmed
INSM
$28.8B
| $50.4M | 2.12% | 2,520,901 +1,290,101 | +105% | +$25.8M |
|
21
Charles Schwab
SCHW
$174B
| $50.3M | 2.11% | +604,204 | New | +$50.3M |
|
22
Fidelity National Information Services
FIS
$36.5B
| $47M | 1.97% | +693,005 | New | +$47M |
|
23
Sutro Biopharma
STRO
$72.7M
| $45M | 1.89% | 5,565,099 +545,099 | +11% | +$4.4M |
|
24
Starbucks
SBUX
$100B
| $44.4M | 1.87% | +448,041 | New | +$44.4M |
|
25
Dollar General
DG
$23.9B
| $42.8M | 1.8% | +173,850 | New | +$42.8M |
|